An RCT of a Patient-initiated Treatment Service for BEB and HFS
A Randomised Controlled Trial to Explore the Effectiveness and Cost-effectiveness of a Patient-initiated Botulinum Toxin Treatment Model for Blepharospasm and Hemifacial Spasm Compared to Treatment as Usual
Sponsor: City, University of London
Listed as NCT02577224, this NA trial focuses on Blepharospasm and Hemi Facial Spasm and remains completed. Sponsored by City, University of London, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — May 2022 [monthly]
Unknown Status NA
-
Oct 2018 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- City, University of London
- Merz Pharmaceuticals
- Moorfields Eye Hospital NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .